0001415889-17-001664.txt : 20171016 0001415889-17-001664.hdr.sgml : 20171016 20171016160433 ACCESSION NUMBER: 0001415889-17-001664 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171016 DATE AS OF CHANGE: 20171016 EFFECTIVENESS DATE: 20171016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc. CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296791 FILM NUMBER: 171138767 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: CytoCore Inc DATE OF NAME CHANGE: 20060815 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 D 1 primary_doc.xml X0708 D LIVE 0000075439 Medite Cancer Diagnostics, Inc. 4203 SW 34th St Orlando FL FLORIDA 32811 407-996-9630 DELAWARE None CytoCore Inc MOLECULAR DIAGNOSTICS INC AMPERSAND MEDICAL CORP Corporation true David Eugene Patterson 4203 SW 34th St Orlando FL FLORIDA 32811 Executive Officer Director Promoter Michaela Eugene Ott 4203 SW 34th St Orlando FL FLORIDA 32811 Director Michael Eugene Ott 4203 SW 34th St Orlando FL FLORIDA 32811 Director John Eugene Abeles, MD 4203 SW 34th St Orlando FL FLORIDA 32811 Director William Austin Lewis IV 4203 SW 34th St Orlando FL FLORIDA 32811 Director Augusto Eugene Ocana 4203 SW 34th St Orlando FL FLORIDA 32811 Director Eric Eugene Goehausen 4203 SW 34th St Orlando FL FLORIDA 32811 Director Other Health Care $5,000,001 - $25,000,000 06b false 2017-09-26 false true true true true false 25000 Tripoint Global Equities, LLC 143174 None None 1450 Broadway 26th Floor New York NY NEW YORK 10018 MO MISSOURI NY NEW YORK VA VIRGINIA 6856400 5929050 927350 4,560,808 warrants issued exercisable at $0.60 per share. false 0 6 281875 0 Warrants issued equal to 7.5% of the cash proceeds raised by broker exercisable at $0.60 per share 0 MEDITE CANCER DIAGNOSTICS, INC. /s/ David E. Patterson David E. Patterson Chief Executive Officer 2017-10-16